This 6-part podcast mini-series, organized and supported by Bayer, is intended for healthcare professionals practicing in the US. Our aim is to raise awareness of the importance of early diagnosis and appropriate management of chronic kidney disease (CKD) in patients with type 2 diabetes in order to slow progression of CKD and reduce the risk of premature cardiovascular morbidity and mortality.
While primary care clinicians play a crucial role in the care of patients with CKD, a holistic approach to care with multidisciplinary team involvement is essential.
Late identification of CKD in patients with T2D can lead to higher economic costs and increased risks of adverse events.
The current healthcare system values high procedural volumes over value-based care, which can impede on the management of chronic conditions like CKD and T2D.
An initiative in the Indian Health Service can serve as an example of how a systematic population-based approach can implemented for patients with CKD and T2D.
This is episode 6 of a 6-part podcast mini-series, organized and supported by Bayer, is intended for healthcare professionals practicing in the US. Our aim is to raise awareness of the importance of early diagnosis and appropriate management of chronic kidney disease (CKD) in patients with type 2 diabetes in order to slow progression of CKD and reduce the risk of premature cardiovascular morbidity and mortality.
Drs. Susanne B. Nicholas (Nephrologist and Professor of Medicine and Clinical Hypertension Specialist in the Division of Nephrology at UCLA), Radica Alicic (Internist and Clinical Professor at the University of Washington), and Nihar R. Desai (Cardiologist and Associate Professor of Medicine at Yale University) emphasize the key role of primary care clinicians in CKD management while highlighting the need for a multidisciplinary, holistic approach, as delayed CKD detection in T2D patients increases costs and risks.
